SLC16A2 and Allan-Herndon-Dudley syndrome: Due to the great advances in preclinical stages of potential therapies for AHDS, we believe that studies devoted to enhance our understanding about the role of MCT8 in development and the complex changes in the CNS related with this disorder are particularly urgent in order to proceed with an optimal translation of the different therapeutic approaches to patients.